Bangalore-based British Biologicals has partnered Raisio Nutrition, Finland, to manufacture and market 'Colred Benecol', a nutritional supplement which helps reduce cholesterol. | |
| Announcing this at a press conference, V Sridhar, executive director, British Biologicals, said, "The agreement with Rasio is a two-way deal wherein Raisio will sell our products in the Nordic countries and in turn we get to manufacture and sell their cholesterol-reducing drugs in the Indian market. Of these, 'Colred Benecol' is the first product." |
| |
| Colred Benecol has been tested in 40 global clinical trials, including in Bangalore and has been cleared by the US Food and Drug Administration and Foshu of Japan. |
| |
| The product has been recommended by the US National Cholesterol Education Program, the European Union Scientific Committee on Foods and the International Atherosclerosis Society. |
| |
| British Biologicals is active in the India through its protein supplements like B-protin, D-protin, Pulmoplus, Meno-Pro and Medislim. |
| |
| V S Reddy, managing director of British Biologicals, said, the company has been exporting nutraceutical products to 15 countries and was planning to foray into the European and US markets soon. |
| |
| "In the next two months the company will firm up a business partnership in Russia. It is also developing products to suit the requirements of African countries as part of its plan to have a pan-global presence," he added. |
| |
| "The present Indian market for protein through the ethical route (doctor prescription) has been estimated around Rs 550 crore. Of this British Biologicals' share is 23 per cent. The cholesterol product is likely to boost our topline which at present stands at Rs 125 crore," said Sridhar. |
| |
| The company, since its inception in 1988, has built two manufacturing facilities in Bangalore and now, to meet the growing demand in international markets, it is setting up an USFDA-compliant plant in Nigeria. |
| |
|
| |
